Hoth Therapeutics, Inc. financial data

Symbol
HOTH on Nasdaq
Industry
Pharmaceutical Preparations
Location
1177 Avenue Of The Americas, 5 Th Floor Suite 5066, New York, NY
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.21K % +28.3%
Debt-to-equity 9.04 % -31.1%
Return On Equity -98.8 % -35.7%
Return On Assets -90.6 % -40.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.2M shares +199%
Common Stock, Shares, Outstanding 8.04M shares +85%
Entity Public Float 4.9M USD -50%
Common Stock, Value, Issued 804 USD +84.8%
Weighted Average Number of Shares Outstanding, Basic 6.38M shares +87%
Weighted Average Number of Shares Outstanding, Diluted 6.38M shares +87%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.24B USD
Research and Development Expense 3.25M USD -13.1%
General and Administrative Expense 4.97M USD +17.9%
Costs and Expenses 29K USD
Operating Income (Loss) -8.22M USD -3.3%
Nonoperating Income (Expense) 22.5K USD -96.9%
Net Income (Loss) Attributable to Parent -8.19M USD -1.01%
Earnings Per Share, Basic -1.28 USD/shares +46.2%
Earnings Per Share, Diluted -1.28 USD/shares +46.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.04M USD -24.3%
Marketable Securities, Current 24.6K USD
Assets, Current 7.64M USD -24.7%
Operating Lease, Right-of-Use Asset 31.1K USD -43.7%
Other Assets, Noncurrent 85K USD
Assets 7.71M USD -24.7%
Accounts Payable, Current 412K USD +1058%
Accrued Liabilities, Current 391K USD -36.4%
Liabilities, Current 831K USD +22.5%
Operating Lease, Liability, Noncurrent 2.71K USD -89.7%
Liabilities 834K USD +18.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 9.06K USD -66.8%
Retained Earnings (Accumulated Deficit) -60.4M USD -15.7%
Stockholders' Equity Attributable to Parent 6.88M USD -27.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.9M USD +50.5%
Liabilities and Equity 7.71M USD -24.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.72M USD +24.7%
Net Cash Provided by (Used in) Financing Activities 8.91M USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 8.04M shares +85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.62M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.04M USD -24.3%
Deferred Tax Assets, Valuation Allowance 17.7M USD +16.3%
Deferred Tax Assets, Gross 17.7M USD +16.3%
Operating Lease, Liability 31.1K USD -43.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.21M USD -1.3%
Lessee, Operating Lease, Liability, to be Paid 32.8K USD -45.5%
Operating Lease, Liability, Current 28.4K USD -1.64%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.73K USD -90%
Lessee, Operating Lease, Liability, to be Paid, Year One 30.1K USD -8.33%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.71K USD -65.4%
Deferred Tax Assets, Operating Loss Carryforwards 13.4M USD +14.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 67.3M USD +8.99%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 283K USD +48.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%